DailyTickers

AMD — Advanced Micro Devices, Inc.

NASDAQ · Technology · 2 August 2026
$476.15 -1.90% EARNINGS TUE 4 AUG AI ACCELERATORS BELOW 20 & 50-DAY 0 INSIDER BUYS / 180D Score 50 C+
$776.4B
Market Cap
26.5M
Volume
AMD Chart
Click to enlarge

Verdict Express

C+ Neutral 72

AMD is a good company in a bad setup, two sessions before a binary event. The business is accelerating for real: trailing revenue up 37.8% to $37.5B, data centre up 57% year on year to $5.8B last quarter, $8.5B of net cash, and an MI400 and Helios roadmap that finally gives hyperscalers a second credible supplier. None of that is in dispute. The price, the share count and the timing are. The stock trades at 107.5x EV/EBITDA, nearly four times NVIDIA's 28.6x, on a 14.4% operating margin against NVIDIA's 65.6% and an 8.1% return on equity against NVIDIA's 114.3%. Above that price sits a warrant issued to OpenAI in October 2025 for up to 160 million shares at a $0.01 exercise price — about 10% of the share count — whose tranches vest against GPU purchase milestones and against AMD share-price targets running up to $600. The dilution arrives precisely if the bull case works. Meanwhile seven insiders sold 690,258 shares for $221.9M across 101 transactions in 180 days with zero open-market purchases. The stock enters Tuesday's print 18.6% below its 52-week high, below its 20-day and 50-day averages, with a negative MACD, after handing back 7.7% intraday from Friday's high. The business we would own. This entry we would not.

Why Buy

  • Growth is real and accelerating: trailing revenue +37.8%, earnings +91.2%, data centre +57% year on year to $5.8B in Q1 2026
  • Forward P/E of 34.45x against a trailing 158.7x. If the earnings ramp lands, the multiple deflates on its own
  • Balance sheet is strong: $12.35B cash against $3.87B debt, $8.48B net cash, debt-to-equity 0.06. No at-the-market programme, no PIPE, no convertible, no toxic paper — and a buyback running with authorisation left
  • The only credible second source to NVIDIA. Management raised its long-term data-centre CPU market growth forecast above 35% at the Q1 print and guided Q2 revenue to $11.2B
  • Analyst consensus is 28 Buys against 8 Holds, with a $573.15 mean target, 20.4% above the current price

Why Avoid

  • A warrant for up to 160 million shares at $0.01 — roughly 10% of the share count — sits above this price, vesting against GPU purchase milestones and share-price targets up to $600. On a fully diluted basis every per-share metric worsens by about 9%
  • 107.5x EV/EBITDA against NVIDIA at 28.6x and Broadcom at 44.4x. The most expensive of the group on cash flow, with the weakest margins of the profitable names
  • 101 insider sales, zero open-market buys, $221.9M over 180 days at a $321.55 average. The CEO sold 500,000 shares for $157.0M in four identical tranches; the CTO's last sale was at $556.43 on 15 July
  • Free cash flow yield of roughly 1%: between 0.87% and 1.10% depending on which published figure you accept. That is 91x to 115x free cash flow
  • Technically broken short term: below the 20-day ($503.96) and 50-day ($486.27), MACD at -10.32 under its signal, down 8.8% last week while the semiconductor group fell 3.7% and the S&P 500 rose 1.1%

Business Overview

AMD designs high-performance processors and graphics chips and has them manufactured by third-party foundries. Four segments matter, but only one currently sets the share price.

Data Center is what sets the price. It generated $5.8 billion in Q1 2026, up 57% year on year, and is now the majority of revenue. It contains two very different businesses that investors routinely conflate. EPYC server CPUs, where AMD has taken share from Intel for eight consecutive years and has real pricing power. And Instinct AI accelerators — MI300X, MI325X, and the new MI400 series — where AMD is the challenger to NVIDIA and competes largely on price, memory capacity and bandwidth rather than on software ecosystem.

That distinction is the crux of the case. The CPU franchise is a durable share-gain story with defensible economics. The accelerator franchise is a land grab against an incumbent whose CUDA software stack remains the industry default. Today's price assumes both work. At its Advancing AI event, management unveiled the full MI400 line, the Helios rack-scale platform and an MI500 roadmap preview; the flagship MI455X is specified at 40 petaflops of FP4 compute, 432 GB of HBM4 memory and 19.6 TB/s of bandwidth.

Client (Ryzen PC processors), Gaming (console semi-custom and Radeon) and Embedded (the Xilinx FPGA franchise) make up the rest. They are cyclical, slower-growing, and matter mainly as a source of cash and as a cushion when the AI narrative wobbles.

Segments

SegmentRevenue
Data Center$5.8B in Q1 2026, +57% year on year. EPYC server CPUs (durable share gains against Intel) plus Instinct AI accelerators (challenger position against NVIDIA). The majority of revenue and effectively all of the valuation.
ClientRyzen desktop and notebook processors. Steady share gains in a low-growth PC market. Cash generative, not a valuation driver.
GamingSemi-custom console silicon and Radeon graphics. The most cyclical segment, tied to console cycles.
EmbeddedThe Xilinx FPGA franchise acquired in 2022. High gross margin, industrial and communications end markets, in slow recovery.

Recent News

2026-08-04
Q2 2026 earnings, after the close. Consensus revenue about $11.32B (+47.3%), EPS $1.55–$1.62. The company guided $11.2B in May, so the street sits above management's own number. The event. A double-digit implied move on a $776B company.
2026-07-31
Friday's reversal. AMD opened at $510.28, traded to $515.62, closed at $476.15 — handing back 7.7% from the intraday high on 26.5M shares. The stock ended the week down 8.8% while the semiconductor group fell 3.7% and the S&P 500 rose 1.1%. Distribution on the last session before the print.
2026-07-22
AMD and Anthropic announced a 2-gigawatt MI450 deployment, with tens of billions of dollars of customer chip commitments — and AMD taking up to $5B of equity in the customer. Vendor financing. When a supplier funds its own customer, some of the revenue is circular. At 107x EV/EBITDA, quality of revenue is not a footnote.
2026-07-15
CTO Mark Papermaster sold 6,000 shares at $556.43, the highest-priced insider sale of the last 180 days. The stock now trades 14.4% below that price.
2026-06-10
CEO Lisa Su sold 125,000 shares between $449.21 and $476.43 — her fourth identical 125,000-share tranche of the year, after 11 February, 12 March and 13 May. 500,000 shares for $157.0M in five months. Four identical tranches is the signature of a pre-scheduled plan, which is exactly why the absence of any buying matters more than the selling.
2025-10-06
AMD issued OpenAI a warrant for up to 160,000,000 shares at a $0.01 exercise price, alongside an agreement to deploy 6 gigawatts of AMD GPUs. Tranches vest against purchase milestones and against AMD share-price targets escalating to $600. Exercisable through 5 October 2030. About 10% of the share count, struck at a cent. This is the single most load-bearing fact in AMD's capital structure and it sits outside a 180-day filings window.

Fundamentals

MetricValueSignal
Revenue (TTM)$37.45B (+37.8% YoY)Strong acceleration
Earnings growth+91.2%But see the base effect in Risks
Gross margin53.1%NVIDIA 74.1%, Broadcom 76.3%
Operating margin14.4%NVIDIA 65.6% — a 51-point gap
Net margin13.4%NVIDIA 63.0%
Return on equity8.1%NVIDIA 114.3%, Broadcom 37.3%
Return on assets3.6%Capital-intensive for the returns produced
Cash$12.35BFortress
Total debt$3.87BNet cash $8.48B
Debt / equity0.06No leverage risk
Market cap$776.41BEnterprise value $798.59B
Shares outstanding1.631B (1.791B fully diluted for the warrant)The 160M-share OpenAI warrant is about 9.8% dilution at a $0.01 strike
EV / EBITDA107.5xNVIDIA 28.6x, Broadcom 44.4x, Marvell 56.8x
EV / Revenue21.3xNVIDIA 18.6x on far better margins
Trailing P/E158.7xOn GAAP EPS of roughly $3.00
Forward P/E34.5xNVIDIA 15.6x, Broadcom 20.0x, TSMC 18.7x
Price / book11.5xBook value $39.55 per share
PEG ratio1.25Best bull argument — but its denominator is the same 91.2% growth the base effect discredits
Free cash flow yield0.87% – 1.10%91x to 115x free cash flow. Two published figures disagree by 27%, so we give the range, not a point estimate
Beta2.47Moves roughly 2.5x the index
DividendNoneAll capital reinvested
Analyst mean target$573.15+20.4% — 28 Buys vs 8 Holds
Q1 2026 (5 May)Revenue $10.3B (+38%), data centre $5.8B (+57%)Guided Q2 to $11.2B
Q2 2026 consensus (4 Aug)Revenue ~$11.32B (+47.3%), EPS $1.55–$1.62The street sits above the company's own $11.2B guide
What the price implies~18% FCF growth, foreverReverse discounted cash-flow: at a 19.3% cost of capital, $776B requires free cash flow to compound at about 18% a year in perpetuity. At a gentler 1.5 beta it still needs ~12.5%
Cost of capital (our estimate)19.3%Beta 2.469 against a 4.7% risk-free rate. Debt is negligible in the weighting
Interest coverage41.2xEBIT $5.39B against $131M of interest expense (FY2025 annual report). Debt service is a non-issue

Insiders & Institutions

0.40%
Insider Own.
74.1%
Institution Own.

Recent Transactions

DateInsiderTypeSharesValue
2026-07-15Mark PapermasterSale6,000$3.34M
2026-06-15Mark PapermasterSale6,000$3.22M
2026-06-10Lisa SuSale (27 lots)125,000$57.6M
2026-06-02Nora DenzelSale (2 lots)10,447$5.45M
2026-05-20Forrest NorrodSale (9 lots)19,487$8.41M
2026-05-13Lisa SuSale (22 lots)125,000$55.7M
2026-05-08Paul Darren GrasbySale24,376$10.83M
2026-04-24Mark PapermasterSale31,320$10.96M
2026-03-12Lisa SuSale125,000$16.9M
2026-02-17Jean HuSale (9 lots)19,956$4.02M
2026-02-11Lisa SuSale125,000$26.8M

bearish

Short Interest

2.45%
SI % Float
1.36
Days to Cover
0.41%
CTB

39.77M shares short against a 1.62B float. Cheap to borrow, barely over one day to cover. There is no squeeze setup here in either direction, and no meaningful bear position to squeeze.

Options / Derivatives

19,442 (3 Aug expiry)
Call OI
16,502 (3 Aug expiry)
Put OI
Standing open interest 1.18 call/put — but Friday's fresh volume was 1.44 put/call (46,351 puts vs 32,231 calls)
C/P Ratio
$485 (+1.9% above spot)
Max Pain
About 73.5% at the money on the 3 August expiry
IV Mean

Unusual Activity: The single most anomalous contract in the chain is the $425 put: 7,173 contracts traded against 315 of open interest, a 22.8x multiple, at 94.2% implied volatility. The $425 strike sits 0.2% above the 29 July low of $424.03 — money is paying up for protection at precisely the recent floor. Nineteen put strikes were flagged for unusual volume against eleven call strikes. Other large anomalies, all puts: $465 (3,777 vs 192 OI, 19.7x), $490 (1,950 vs 99, 19.7x), $487.50 (1,222 vs 65, 18.8x), $457.50 (1,065 vs 80, 13.3x). IMPORTANT CAVEAT, and it changes the reading: every one of these contracts expires Monday 3 August, the day BEFORE the print. This is not an earnings hedge. It is either positioning for Monday alone — ISM manufacturing at 16:00 CET and Palantir's results after the close, both read-across events for the AI complex — or it is roll activity into later expiries our feed does not carry. We flag the pattern; we do not claim to know which.

Technical Analysis

RSI (14)45.2
EMA 20$503.96
EMA 50$486.27
EMA 200$342.99
MACD-10.320
Signal-1.320
ATR (14)$40.33
BELOW EMA20 BELOW EMA50 MACD NEGATIVE RSI NEUTRAL ATR 8.5% -18.6% FROM HIGH
Supports: $455.00 / $429.56 / $424.03
Resistances: $486.27 / $503.96 / $515.62 / $584.73

Technical Setup

The stock sits below its 20-day ($503.96) and 50-day ($486.27) averages and 38.8% above its 200-day ($342.99): a broken short-term trend inside an intact long-term one. RSI at 45.18 is neutral. MACD at -10.32 is below its signal line at -1.32, so momentum is negative and not yet turning. Average true range is $40.33, 8.5% of the share price, which is what a double-digit implied earnings move looks like in practice. The most informative bar is Friday 31 July: open $510.28, high $515.62, close $476.15. Handing back 7.7% from the high on the last session before a print tells you who was selling into strength. Levels that matter: $486 then $504 on the way up, the two moving averages in that order; $455, then $429.56 and the 29 July low of $424.03 on the way down. The heaviest put activity in the chain clusters on that last level.

Macro Context

IndicatorValueSignal
Market regimeRECOVERY 0.72 / risk-on 57.9%Supportive but not euphoric
VIX 9-day13.05The index market prices almost no risk for the next two weeks
Semiconductor group, last week-3.7%Rallied 6.9% on 30 July, gave it back
AMD vs its own group-8.8% vs -3.7%Underperformed the sector by 5 points in one week
10-year Treasury4.745%Long-duration growth is the first casualty when rates rise
30-year Treasury5.275%Highest close since July 2007 — a direct headwind to 100x multiples

Regime: recovery

AMD is a maximum-duration asset: 2.47 beta, no dividend, and a valuation that discounts cash flows many years out. The macro backdrop of the past week has been quietly hostile to exactly that profile. The 30-year Treasury closed at 5.275%, its highest since July 2007, and the 10-year at 4.745%. When the discount rate on long-dated cash flows rises, the stocks that lose most are those whose value sits furthest in the future — which is precisely a company at 107x EV/EBITDA. Note too that three Federal Reserve officials dissented in favour of a rate hike on 29 July, so the familiar reflex of buying weak macro data on the expectation of cuts is not currently reliable. That is the backdrop into which AMD reports.

Risk Analysis

Risk Profile: High

A high-beta, high-multiple asset reporting binary results in two sessions, in a broken short-term trend, with unanimous insider selling, a defensively positioned options chain, and a 160-million-share warrant struck at a cent sitting above the price. The balance sheet is clean; the share count is not. Nothing here threatens solvency. Everything here is about what you pay and when.

The share count is not clean: a 160M-share warrant sits above this price

High
  • On 6 October 2025 AMD issued OpenAI a warrant for up to 160,000,000 shares at a $0.01 exercise price, alongside an agreement to deploy 6 gigawatts of AMD GPUs. That is roughly 10% of the 1.63B shares outstanding, struck at a cent.
  • Tranches vest against Instinct GPU purchase milestones — the first gigawatt for the first tranche, 6 gigawatts for the full amount — and against specified AMD share-price targets escalating to $600 for the final tranche. Exercisable through 5 October 2030.
  • The structure has a consequence worth spelling out: the dilution vests precisely if the bull case works. The better the stock does, the more of the 160 million shares are handed over at a cent.
  • On a fully diluted 1.791B share count, every per-share metric worsens by about 9%, and the enterprise value the market is really paying rises accordingly.
  • This is disclosed, commercially rational and arguably a good trade for AMD — locking in an anchor customer for a challenger accelerator. It is not a governance red flag. But a valuation that ignores it is understating what a buyer actually pays.
Probability
Impact

Vendor financing: AMD is funding its own customers

Medium
  • On 22 July 2026 AMD announced a 2-gigawatt MI450 deployment with Anthropic, with tens of billions of dollars of customer chip commitments — and AMD taking up to $5B of equity in that customer.
  • Combined with the OpenAI warrant, a pattern emerges: AMD is buying accelerator share with equity, its own or its customers'.
  • When a supplier finances the buyer, part of the reported revenue is circular. That does not make it fake, but it does make it lower quality than an arm's-length sale.
  • At 107x EV/EBITDA the market is paying a premium multiple for revenue whose independence deserves scrutiny. This belongs in the price, and we do not think it currently is.
Probability
Impact

The +235% growth headline is a base-effect artefact

High
  • Consensus for Tuesday is $1.55 to $1.62 non-GAAP EPS against $0.48 a year ago. Nearly every headline will say growth of roughly +235%.
  • But Q2 2025 absorbed approximately $800M of inventory and related charges tied to US export controls on the Instinct MI308, and AMD disclosed that this reduced earnings per share by about $0.43.
  • A clean base is therefore roughly $0.91, not $0.48. Against $0.91, a $1.62 print is about +78% — excellent, and roughly one third of the number that will lead the coverage.
  • The same trap sits in the margin line. AMD stated non-GAAP gross margin would have been about 54% excluding the charge, against the 43% reported. A 54% print on Tuesday will be written up as eleven points of expansion when the underlying move is close to flat.
  • This is not an accusation of manipulation. It is a disclosed one-off sitting in a comparison base. But if you buy the headline growth rate, you are buying an accounting comparison, not a business inflection.
Probability
Impact

Valuation: the most expensive, the least profitable

High
  • 107.5x EV/EBITDA against NVIDIA at 28.6x, Marvell at 56.8x and Broadcom at 44.4x.
  • 34.5x forward earnings against NVIDIA at 15.6x, Broadcom at 20.0x and TSMC at 18.7x. AMD trades at more than twice NVIDIA's forward multiple.
  • Operating margin 14.4% against NVIDIA's 65.6%. Return on equity 8.1% against NVIDIA's 114.3%.
  • Free cash flow yield of roughly 1%: 91x to 115x free cash flow depending on which published figure you accept.
  • We do not publish a price target here, and the reason is worth stating. Run a discounted cash-flow with AMD's own beta of 2.469 and you get a 19.3% cost of capital; discount $6.7–8.6B of free cash flow at that rate against a conservative terminal growth cap and the model returns a value around 6% of the market capitalisation. That output is an artefact of applying a mature-company discipline to a hyper-growth company, and we would not put it in front of a reader as a target.
  • The useful version is the same arithmetic run backwards. To justify $776B at a 19.3% cost of capital, free cash flow has to compound at about 18% a year in perpetuity. Halve the beta to 1.5 and the requirement is still about 12.5% forever. Revenue is currently growing 37.8%, so the next few years clear that bar comfortably. Whether anything clears it in perpetuity is the actual question the price is asking.
Probability
Impact

101 insider sales, zero buys, $221.9M

High
  • Over the 180 days to 15 July: 101 sale transactions, 690,258 shares, $221.9M, at a volume-weighted average of $321.55. Open-market purchases: zero.
  • Seven insiders sold, including the CEO, the CFO, the CTO, the General Counsel, two EVPs and a director. This is not one executive buying a house.
  • CEO Lisa Su sold 500,000 shares for $157.0M in four tranches of exactly 125,000 shares each — 11 February, 12 March, 13 May and 10 June. Her latest reported post-transaction holding is 2,866,899 shares. We do not attempt to reconcile the two: option exercises and vesting add shares between sales, and the balancing items are not disclosed at that grain.
  • The selling accelerated as the price rose: $35M in February, $19M in March, $21M in April, then $78M in May and $65M in June.
  • The strongest caveat, and it cuts against us: four identical 125,000-share tranches is the exact signature of a pre-scheduled 10b5-1 plan, and a plan carries no information about a manager's current view. Treat the sales as noise if you like. What a plan does not explain is the complete absence of buying by anyone, in any month, at any price, including through an 18.6% drawdown.
Probability
Impact

The options chain is paying up for downside

Medium
  • Friday's flow was 46,351 puts against 32,231 calls, a 1.44 put/call volume ratio, while standing open interest remains call-heavy at 1.18. Fresh money is rotating defensive against an existing bullish book.
  • The volatility skew is steep and one-sided: 16.8 points of extra implied volatility on the $425 put versus the $525 call at comparable distance from spot.
  • The $425 put traded 7,173 contracts against 315 of open interest — a 22.8x anomaly — at a strike 0.2% above the 29 July low.
  • Nineteen put strikes were flagged for unusual volume against eleven call strikes.
  • Caveat that cuts against the bearish reading: all of these contracts expire Monday, before the print. This is Monday-session positioning or roll activity, not an earnings hedge. We report the pattern and the caveat together.
Probability
Impact

NVIDIA's software moat is the structural risk

High
  • AMD competes on price, memory capacity and bandwidth. NVIDIA competes on CUDA, where a decade of developer tooling lives.
  • Hyperscalers have a strong commercial interest in funding a second source. That is a real tailwind, but it is a customer preference and preferences get repriced.
  • The MI400 line and Helios platform are genuinely competitive on paper. Silicon specification is not the binding constraint; software migration cost is.
  • The bull case requires AMD to hold a durable double-digit accelerator share. The bear case is that it stays a price-taking second source with structurally lower margins — which is precisely what a 14.4% operating margin against 65.6% currently describes.
Probability
Impact

Export controls: the precedent is already in the numbers

Medium
  • The $800M MI308 charge in Q2 2025 was the direct consequence of a US export restriction. This is not hypothetical; it has happened once and cost a quarter's earnings.
  • China exposure remains a live policy variable for every US accelerator vendor.
  • A 107x multiple does not price a repeat. Multiples that high assume an uninterrupted ramp.
Probability
Impact

What is genuinely clean here

Low
  • No at-the-market equity programme, no PIPE, no convertible, no toxic financing, no reverse split. The shelf on file is a standard automatic S-3ASR registration, which every large issuer carries as available capacity.
  • Balance sheet: $12.35B cash against $3.87B debt, $8.48B net cash, debt-to-equity 0.06. A buyback is running with authorisation remaining.
  • Squeeze risk in either direction: 2.45% of float short, 1.36 days to cover, 0.41% cost to borrow. There is nothing to squeeze.
  • We flag this because inventing caveats is as dishonest as hiding them. But note what changed in this edition: an earlier draft of this note claimed AMD had no warrant overhang, on the basis of a 180-day filings window. That window ended after the largest equity issuance in the company's recent history. The warrant card above is the correction.
Probability
Impact

Risk Synthesis

Why downgrade the same company from B to C+ while its revenue accelerates? Because a grade is not a verdict on a business, it is a verdict on the risk and reward available to a buyer today. In February we graded AMD B at $207, with a forward multiple that left room. Since then the business improved and the share price tripled off its low. The four eliminatory criteria in our A-grade screen now read: guidance raised — pass; five consecutive earnings beats — fail, our verified history shows three beats and one marginal miss across four quarters; forward P/E under 35x — pass, at 34.45x, by half a point; price within 3% of its 20-day average — fail, at 5.52% below. Two of four fail, so the A grades are off the table by construction, and the composite lands at 50 out of 100. The facts that made the company more attractive are the same facts that made the entry less attractive. We grade the entry.

Trade Idea

Entry Zone
$440.00
Zone $430–441, limit orders only, nothing before the print, valid from Wednesday 5 August. Hard cap at $441: above that the reward-to-risk drops under 1.5 against the $412 stop, so a fill at $445 is not the same trade. No entry within 3% of today's $476.15 passes our filter, because a binary event sits between here and any sensible stop.
Stop Loss
$412.00
-6.4% (from $440)
Target 1
$486.00
+10.5% (from $440)
Target 2
$520.00
+18.2% (from $440)
Risk/Reward
1:1.64 at $440 — 1.55 at the $441 cap, 3.11 at $430
10–20 sessions

Thesis

Two plans, chosen on Wednesday morning by what the print actually says rather than by what we expect it to say. PRIMARY — the pullback. If the results are good but the stock sells into $430–441 while holding above the 29 July low of $424.03, that is a confirmed catalyst bought at a price the event itself created. Entry zone $430–441 (limit only, hard cap $441), stop $412, first target $486 at the 50-day, second target $520 — scaling out into $512–515 rather than resting size at $520, which sits 0.85% above Friday's $515.62 swing high. Reward-to-risk runs 1.64 at a $440 fill, 1.55 at the $441 cap and 3.11 at $430, so where you get filled decides most of the outcome. Be aware the $412 stop is 0.69 times the $40.33 average true range — a deliberately tight stop on a 2.47-beta name in its most volatile window, which buys a defined loss at the cost of a higher stop-out rate. Size in two tranches for that reason. The options market has already marked this zone: the heaviest unusual put volume of the whole chain sits at the $425 strike. ALTERNATIVE — the reclaim. If the print is strong and the stock closes back above its 20-day at $503.96, enter there with the stop under the 50-day at $483, which is the genuine invalidation of a reclaim: 1.96 to $545 and 3.85 to $584.73. Half size, because a reclaim after a broken trend fails more often than it works. WHAT WE DO NOT DO: buy before Tuesday's close, hold through the print, or use a market order at Wednesday's open. On a name with an 8.5% average daily range, the opening auction is where retail pays the spread.

Catalysts

  • Tuesday 4 August, after the close: Q2 2026 results. Consensus revenue about $11.32B (+47.3%), EPS $1.55–$1.62, against company guidance of $11.2B.
  • The number that matters: data-centre revenue and the Q3 guide. Last quarter data centre was $5.8B, up 57%. The market pays for the slope.
  • Gross margin — read it against the roughly 54% ex-charge figure from Q2 2025, not the 43% reported. That is where the headline trap sits.
  • Any disclosure on warrant tranche vesting: which purchase milestones have been met, and how many of the 160 million shares are now earned.
  • Monday 3 August: ISM manufacturing and Palantir after the close, both read-across events for the AI complex.
  • Friday 7 August: US employment report. A 10-20 session hold entered on Wednesday runs straight through it, on a 2.47-beta long-duration name — the single macro risk this plan carries by construction.

Invalidation

  • A close below $424.03, the 29 July low, cancels an unfilled entry and the second tranche. It does not move the $412 stop on a position already open, and there are no adds below invalidation.
  • If the print is weak and the stock opens below $424 on Wednesday, there is no plan. We do not buy a broken high-multiple growth name on a guidance miss.
  • If data-centre revenue grows less than 40% year on year, the second-source thesis needs re-underwriting regardless of the headline EPS.
  • SIZING: 5% of capital maximum. That is not arbitrary — realised volatility is 82.7% annualised over 60 sessions and correlation to the semiconductor complex is 0.90, which takes a 20% base position down to a 7.0% ceiling. The 5% sits inside it. At 0.90 correlation this is not a diversifier: if you already hold semis, this is the same bet at a higher multiple.

Disclaimer

This analysis is provided for informational and educational purposes only. It does not constitute financial advice, investment recommendation, or solicitation to buy or sell any security.

Past performance is not indicative of future results. All investments involve risk, including the possible loss of principal. Always conduct your own research and consult a licensed financial advisor before making investment decisions.

Data sourced from real-time market data, Yahoo Finance, SEC EDGAR, and public market data. Accuracy is not guaranteed.

Verdict Business News Fundamentals Insiders Technical Risks Trade